XERS

| Held by: VTI IWM VXF IWO XPH SCHA VTWO FESM VHT IWC

Index	RUT	P/E	95.27	EPS (ttm)	0.07	Insider Own	6.87%	Shs Outstand	172.56M	Perf Week	-4.44%
Market Cap	1.08B	Forward P/E	16.96	EPS next Y	0.37	Insider Trans	-2.66%	Shs Float	160.78M	Perf Month	1.96%
Enterprise Value	1.22B	PEG	-	EPS next Q	0.01	Inst Own	53.04%	Short Float	9.89%	Perf Quarter	-8.50%
Income	12.01M	P/S	3.42	EPS this Y	4425.82%	Inst Trans	2.46%	Short Ratio	8.27	Perf Half Y	-17.79%
Sales	314.85M	P/B	82.76	EPS next Y	153.44%	ROA	3.39%	Short Interest	15.89M	Perf YTD	-20.51%
Book/sh	0.08	P/C	9.64	EPS next 5Y	-	ROE	-	52W High	10.08 -38.10%	Perf Year	30.27%
Cash/sh	0.65	P/FCF	22.67	EPS past 3/5Y	- -	ROIC	4.53%	52W Low	4.30 45.12%	Perf 3Y	119.72%
Dividend Est.	-	EV/EBITDA	25.16	Sales past 3/5Y	38.33% 70.20%	Gross Margin	82.45%	Volatility	4.66% 4.35%	Perf 5Y	81.66%
Dividend TTM	-	EV/Sales	3.89	EPS Y/Y TTM	123.74%	Oper. Margin	11.40%	ATR (14)	0.28	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.50	Sales Y/Y TTM	41.47%	Profit Margin	3.81%	RSI (14)	51.07	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	2.12	EPS Q/Q	120.83%	SMA20	0.35%	Beta	0.78	Target Price	11.29
Payout	0.00%	Debt/Eq	19.87	Sales Q/Q	38.27%	SMA50	5.09%	Rel Volume	0.63	Prev Close	6.38
Employees	435	LT Debt/Eq	19.39	Earnings	May 07 BMO	SMA200	-12.35%	Avg Volume	1.92M	Price	6.24
IPO	Jun 21, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	470.37% 3.28%	Trades		Volume	1,218,290	Change	-2.19%

Xeris Biopharma Holdings Inc

Upgrade your Finviz experience